Related references
Note: Only part of the references are listed.Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure
Justin M. Vader et al.
JACC-HEART FAILURE (2022)
OUTSTEP-HF: randomised controlled trial comparing short-term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction The PARALLAX Randomized Clinical Trial
Burkert Pieske et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction - Results From the PARALLEL-HF Study -
Hiroyuki Tsutsui et al.
CIRCULATION JOURNAL (2021)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
Jelena P. Seferovic et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2020)
Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
Gaia Cattadori et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Akshay S. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study
Yong Huo et al.
JOURNAL OF CLINICAL HYPERTENSION (2019)
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Amil M. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension
J. Jordan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Long-term neprilysin inhibition - implications for ARNIs
Duncan J. Campbell
NATURE REVIEWS CARDIOLOGY (2017)
Natriuretic peptide control of energy balance and glucose homeostasis
Marine Coue et al.
BIOCHIMIE (2016)
An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)
Colin D. Bicknell et al.
EUROPEAN HEART JOURNAL (2016)
Microvascular endothelial dysfunction in heart failure with preserved ejection fraction
Carolyn S. P. Lam et al.
HEART (2016)
Diabetes mellitus statistics on prevalence and mortality: facts and fallacies
Paul Zimmet et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Atrial Natriuretic Peptide and Type 2 Diabetes Development - Biomarker and Genotype Association Study
Amra Jujic et al.
PLOS ONE (2014)
Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
Orly Vardeny et al.
JACC-HEART FAILURE (2014)
Prospective Evaluation of B-type Natriuretic Peptide Concentrations and the Risk of Type 2 Diabetes in Women
Brendan M. Everett et al.
CLINICAL CHEMISTRY (2013)
NH2-Terminal Pro-Brain Natriuretic Peptide and Risk of Diabetes
Mariana Lazo et al.
DIABETES (2013)
Brown adipose tissue regulates glucose homeostasis and insulin sensitivity
Kristin I. Stanford et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmo Diet and Cancer Study
Martin Magnusson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Atrial Natriuretic Peptide and Adiponectin Interactions in Man
Andreas L. Birkenfeld et al.
PLOS ONE (2012)
Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes The TRANSCEND study
Joshua I. Barzilay et al.
DIABETES CARE (2011)
Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism A randomized controlled trial
Nynke J. van der Zijl et al.
DIABETES CARE (2011)
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
E. Imai et al.
DIABETOLOGIA (2011)
Irbesartan in Patients with Atrial Fibrillation
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies
Roman Pfister et al.
PLOS MEDICINE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes Three Randomized Trials
Rudy Bilous et al.
ANNALS OF INTERNAL MEDICINE (2009)
Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure
Osamu Tsukamoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding
Fleur Gregoire et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue
C. Moro et al.
DIABETOLOGIA (2007)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials
H Abuissa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie et al.
DIABETES CARE (2005)
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - Part 1. A meta-analysis of randomised clinical trials
AJ Scheen
DIABETES & METABOLISM (2004)
The Study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial
H Lithell et al.
JOURNAL OF HYPERTENSION (2003)
Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats
V Arbin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Ramipril and the development of diabetes
S Yusuf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
